Lila Sciences
AI that discovers, designs, and validates
Cambridge, MA, US
Lila Sciences operates as an AI science platform company that licenses its AI Science Factory platform to partners across biotech, pharmaceutical, agriculture, and materials science sectors. It provides AI agents and autonomous science capabilities to accelerate research and drug discovery processes, combining advanced robotics with artificial intelligence to accelerate discovery across materials science, life science, and chemistry.
How We Help
Problem Statement
To accelerate research and drug discovery processes, and materials development across various sectors.
Core Technology
AI Science Factory, advanced robotics, artificial intelligence, autonomous experimentation platform, NVIDIA Megatron library for LLM training
Key Differentiators
human scientific oversight within its AI frameworks; does not develop its own therapeutic candidates; licenses AI Science Factory platform to partners
Company Info
- Business Model
- B2B SaaS
- Founded
- 2023
- Total Funding
- 550,000,000
- Website
- www.lila.ai/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Platform-stage technology. Demonstrated genetic medicine constructs exceeding commercial therapeutics in bench validation. Multiple pathways toward clinical translation through industry partners
MedStartr Index Score
?What do you think of Lila Sciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.